Skip to main content
KPTI filings

Corporate insider profile

Reshma Rangwala Filing Activity

Latest reported as EVP & Chief Medical Officer of Karyopharm Therapeutics Inc. (KPTI).

Purchase filings
0
Reported companies
1
Net open-market value
-$7,890.06
Latest transaction
May 14, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
May 14, 2026Karyopharm Therapeutics Inc. (KPTI)EVP & Chief Medical OfficerSale408$9.50$3,876
Apr 21, 2026Karyopharm Therapeutics Inc. (KPTI)EVP & Chief Medical OfficerSale449$8.94$4,014